{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:28Z","timestamp":1792785988578,"version":"4.5.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"National Cancer Center Research and Development","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jjco\/hyx059","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T07:08:37Z","timestamp":1493104117000},"page":"671-677","source":"Crossref","is-referenced-by-count":69,"title":["Current approach and future perspective for ductal carcinoma in situ of the breast"],"prefix":"10.1093","volume":"47","author":[{"given":"Chizuko","family":"Kanbayashi","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Niigata Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"key\n\t\t\t\t20180315010305_hyx059C1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for dshis","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180315010305_hyx059C2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ","volume":"41","author":"Kerlikowske","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key\n\t\t\t\t20180315010305_hyx059C3","author":"Projected cancer incidence in Japan","year":"2016"},{"key":"key\n\t\t\t\t20180315010305_hyx059C4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-015-1904-7","article-title":"Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis","volume":"15","author":"Stuart","year":"2015","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20180315010305_hyx059C6","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijrobp.2011.12.092","article-title":"Long-term outcome in patients with ductal carcinoma in situ treated with breast\u2014conserving therapy: implications for optimal follow-up strategies","volume":"83","author":"Shaitelman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180315010305_hyx059C7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1748-717X-7-177","article-title":"Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study","volume":"7","author":"Vidali","year":"2012","journal-title":"Radiat Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1634\/theoncologist.12-11-1276","article-title":"Current treatment and clinical trial developments for ductal carcinoma in situ of the breast","volume":"12","author":"Boughey","year":"2007","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20180315010305_hyx059C9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180315010305_hyx059C10","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/cncr.11761","article-title":"The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up","volume":"98","author":"Lara","year":"2003","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C11","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1245\/s10434-012-2287-5","article-title":"Outcome of patients with ductal carcinoma in sim and sentinel node biopsy","volume":"19","author":"Meretoja","year":"2012","journal-title":"Ann surg Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-5-28","article-title":"Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast","volume":"5","author":"Zavagno","year":"2005","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/bjc.2012.168","article-title":"Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay","volume":"106","author":"Osako","year":"2012","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","article-title":"Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates","volume":"218","author":"Jackman","year":"2001","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180315010305_hyx059C15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5858\/2002-126-0039-PIITES","article-title":"Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ","volume":"126","author":"Renshaw","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1245\/ASO.2003.11.011","article-title":"The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic14-gauge needle biopsy","volume":"10","author":"Hoorntje","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cursur.2004.09.011","article-title":"Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy","volume":"62","author":"Mittendorf","year":"2005","journal-title":"Curr Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjsurg.2005.06.011","article-title":"An update of sentinel lymph node mapping in patients with ductal carcinoma in situ","volume":"190","author":"Wilkie","year":"2005","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","article-title":"Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases","volume":"98","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20180315010305_hyx059C21","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.22216","article-title":"Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ","volume":"107","author":"Huo","year":"2006","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjsurg.2010.09.032","article-title":"Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ","volume":"202","author":"Miyake","year":"2011","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ejrad.2014.01.010","article-title":"Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer","volume":"83","author":"Park","year":"2014","journal-title":"Eur J Radiol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180315010305_hyx059C25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ultrasmedbio.2017.01.008","article-title":"Ultrasound image classification of Ductal Carcinoma in Situ (DCIS) of the breast: analysis of 705 DCIS lesions","volume":"43","author":"Watanabe","year":"2017","journal-title":"Ultrasound Med Biol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C26","volume-title":"Guideline for Breast Ultrasound-Management and Diagnosis","author":"Japan Association of Breast and Thyroid Sonology","year":"2014","edition":"3rd edn"},{"key":"key\n\t\t\t\t20180315010305_hyx059C27","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 \u2013 a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group","volume":"24","author":"Bijker","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","article-title":"Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast","volume":"26","author":"Holmberg","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key\n\t\t\t\t20180315010305_hyx059C31","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315010305_hyx059C32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","article-title":"UK Coordinating Committee on Cancer Research; Ductal Carcinoma in situ Working Party; DCIS trialists in the UK, Australia, and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial","volume":"362","author":"Houghton","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315010305_hyx059C34","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","volume":"387","author":"Forbes","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315010305_hyx059C35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(15)01168-X","article-title":"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Margolese","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315010305_hyx059C36"},{"key":"key\n\t\t\t\t20180315010305_hyx059C37","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/cncr.21406","article-title":"The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis","volume":"104","author":"Warren","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C38","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988\u20132001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","article-title":"Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience","volume":"28","author":"Fisher","year":"2001","journal-title":"Semin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","article-title":"The influence of margin width on local control of ductal carcinoma in situ of the breast","volume":"340","author":"Silverstein","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjsurg.2006.04.002","article-title":"The receptor expression pattern in ductal carcinoma in situ predicts recurrence","volume":"192","author":"Kepple","year":"2006","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C42","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1158\/1078-0432.CCR-04-1633","article-title":"Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast","volume":"11","author":"Barnes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180315010305_hyx059C43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","article-title":"The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast","volume":"186","author":"Silverstein","year":"2003","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u2018reservoir: for ductal carcinoma in situ of the breast: how much more breast cancer can we find","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C45","first-page":"223","article-title":"Long-term follow-up of in situ carcinoma of the breast","volume":"11","author":"Eusebi","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180315010305_hyx059C47","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C48","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C49","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Independent","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180315010305_hyx059C50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","article-title":"The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening","volume":"18","author":"van Luijt","year":"2016","journal-title":"Breast Cancer Res"},{"key":"key\n\t\t\t\t20180315010305_hyx059C51","first-page":"377","article-title":"Over-diagnosis in Breast Cancer Screening","volume":"30","author":"Shimada","year":"2015","journal-title":"J Breast Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C52","article-title":"Surgical excision without whole breast irradiation for complete resection of ductal carcinoma in situ identified using strict, unified criteria","author":"Sakai","year":"2016","journal-title":"Am J Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C54"},{"key":"key\n\t\t\t\t20180315010305_hyx059C55","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","article-title":"Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180315010305_hyx059C56","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"key":"key\n\t\t\t\t20180315010305_hyx059C57","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/jamainternmed.2013.8405","article-title":"Impact of ductal carcinoma in situ terminology on patient treatment preferences","volume":"173","author":"Omer","year":"2013","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180315010305_hyx059C58","doi-asserted-by":"crossref","first-page":"e008094","DOI":"10.1136\/bmjopen-2015-008094","article-title":"How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey","volume":"5","author":"McCaffery","year":"2015","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180315010305_hyx059C59","doi-asserted-by":"crossref","first-page":"OT2","DOI":"10.1158\/0008-5472.SABCS13-OT2-3-01","article-title":"The LORIS trial: a multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ","volume":"73","author":"Francis","year":"2013","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180315010305_hyx059C60","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180315010305_hyx059C61","first-page":"OT3","article-title":"The LORD trial: a randomized, non-inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ","volume":"75","author":"Elshof","year":"2014","journal-title":"SABCS"},{"key":"key\n\t\t\t\t20180315010305_hyx059C62","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/47\/8\/671\/24356840\/hyx059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T17:51:21Z","timestamp":1658944281000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/47\/8\/671\/3807293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,9]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx059","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,5,9]]}}}